Suppr超能文献

欧洲癌症前瞻性调查与营养-波茨坦研究中红细胞膜中 FADS1 FADS2 基因簇的遗传变异与 n-6PUFA 组成。

Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study.

机构信息

Technische Universität München, Freising, Germany.

出版信息

Br J Nutr. 2010 Dec;104(12):1748-59. doi: 10.1017/S0007114510002916. Epub 2010 Aug 9.

Abstract

Delta-5 (D5D) and delta-6 (D6D) desaturases are key enzymes in PUFA metabolism. Several factors (e.g. hyperglycaemia, hypertension, blood lipids, statins and fatty acids in diet and biological tissues) may influence desaturase activity. The goals were to evaluate the associations between variation in genes encoding these desaturases (FADS1 and FADS2) and blood concentrations of n-6 PUFA and estimated D5D and D6D activities (evaluated as product/precursor ratio), and to investigate whether other factors influencing the activity of desaturases modify these associations. A random sample of 2066 participants from the European Prospective Investigation into Cancer and Nutrition-Potsdam study (n 27 548) was utilised in the analyses. Crude and adjusted associations between rs174546 genotypes (reflecting genetic variation in the FADS1 FADS2 gene cluster), n-6 PUFA in erythrocytes and estimated desaturase activities were evaluated using multiple linear regression. Potential effect modification was determined by performing stratified analyses and evaluating interaction terms. We found rs174546 genotypes to be related to linoleic (r² 0·060), γ-linolenic (r² 0·041), eicosadienoic (r² 0·034), arachidonic (r² 0·026), docosatetraenoic acids (r² 0·028), estimated D6D activity (r² 0·052) and particularly strongly to dihomo-γ-linolenic acid (DGLA, r² 0·182) and D5D activity (r² 0·231). We did not observe effect modifications with regard to the estimated D5D activity, DGLA and arachidonic acid (AA) for most of the factors evaluated; however, the genetic effect on D5D activity and DGLA may be modified by the dietary n-6:n-3-ratio (P-values for interaction: 0·008 and 0·002), and the genetic effect on DGLA and AA may be modified by lipid-lowering medication (P-values for interaction: 0·0004 and 0·006). In conclusion, genetic variation in the FADS1 FADS2 gene cluster affects n-6 PUFA profiles in erythrocytes reflecting altered D5D activity.

摘要

德尔塔-5(D5D)和德尔塔-6(D6D)去饱和酶是多不饱和脂肪酸代谢中的关键酶。许多因素(如高血糖、高血压、血脂、他汀类药物和饮食及生物组织中的脂肪酸)可能会影响去饱和酶的活性。本研究的目的是评估编码这些去饱和酶(FADS1 和 FADS2)的基因变异与血液中 n-6 多不饱和脂肪酸和估计的 D5D 和 D6D 活性(通过产物/前体比值来评估)之间的关系,并研究影响去饱和酶活性的其他因素是否会改变这些关联。本研究利用欧洲癌症前瞻性调查与营养-波茨坦研究(n 27 548)中的一个随机样本 2066 名参与者进行了分析。使用多元线性回归评估 rs174546 基因型(反映 FADS1 FADS2 基因簇的遗传变异)、红细胞中 n-6 多不饱和脂肪酸和估计的去饱和酶活性之间的粗关联和调整关联。通过分层分析和评估交互作用项来确定潜在的效应修饰。我们发现 rs174546 基因型与亚油酸(r² 0·060)、γ-亚麻酸(r² 0·041)、二十碳二烯酸(r² 0·034)、花生四烯酸(r² 0·026)、二十二碳六烯酸(r² 0·028)、估计的 D6D 活性(r² 0·052)和二高-γ-亚麻酸(DGLA,r² 0·182)和 D5D 活性(r² 0·231)密切相关。对于大多数评估的因素,我们没有观察到估计的 D5D 活性、DGLA 和花生四烯酸(AA)方面的效应修饰;然而,D5D 活性和 DGLA 的遗传效应可能受到膳食 n-6:n-3 比值的修饰(交互作用的 P 值:0·008 和 0·002),而 DGLA 和 AA 的遗传效应可能受到降脂药物的修饰(交互作用的 P 值:0·0004 和 0·006)。总之,FADS1 FADS2 基因簇的遗传变异影响红细胞中的 n-6 多不饱和脂肪酸谱,反映 D5D 活性的改变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验